[1]吕红梅 府裕琦 陈熙 孙路路.PIVAS运行对静脉用药集中调配管理专业组影响的调查分析[J].中国卫生质量管理,2024,31(04):021-25.[doi:10.13912/j.cnki.chqm.2024.31.4.05]
　LV Hongmei,FU Yuqi,CHEN Xi,et al.Investigation and Analysis of the Influence of PIVAS Operation on the Pharmacy Intravenous Admixture Service Professional Group[J].Chinese Health Quality Management,2024,31(04):021-25.[doi:10.13912/j.cnki.chqm.2024.31.4.05]
点击复制

PIVAS运行对静脉用药集中调配管理专业组影响的调查分析()
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第31卷
期数:
2024年04期
页码:
021-25
栏目:
特别关注
出版日期:
2024-04-15

文章信息/Info

Title:
Investigation and Analysis of the Influence of PIVAS Operation on the Pharmacy Intravenous Admixture Service Professional Group
作者:
吕红梅 府裕琦 陈熙 孙路路
国家卫生健康委医院管理研究所
Author(s):
LV Hongmei; FU Yuqi; CHEN Xi; et al
National Institute of Hospital Administration,National Health Commission
关键词:
静脉用药调配中心; 静脉用药集中调配管理专业组; 认知状况
Keywords:
Pharmacy Intravenous Admixture Service(PIVAS); Professional Group of Pharmacy Intravenous Admixture Services; Cognitive Status
分类号:
R197
DOI:
10.13912/j.cnki.chqm.2024.31.4.05
文献标志码:
A
摘要:
目的了解PIVAS运行对所在地区静脉用药集中调配管理专业组的建立、隶属关系和工作内容等的影响。方法采用问卷调查方法，通过中国药师协会静脉用药集中调配工作委员会对医疗机构PIVAS负责人进行问卷调查。结果761个PIVAS中，有30个省（自治区、直辖市）的665个（87.39%)PIVAS建立了专业组；有22个省（自治区、直辖市）的96个（12.61%)PIVAS未建立专业组。建立专业组的665个PIVAS中，有365个（54.89%）PIVAS所在省（自治区、直辖市）的专业组属于省级卫生健康行政部门或其领导下的药学、药事管理、临床药学、静脉用药调配、医疗质量控制中心。结论我国静脉用药集中调配管理省级专业组建设相对较弱，未能在监督指导中发挥核心作用，应强化省级专业组在静脉用药集中调配管理中的功能定位，提升监督管理质量和效率。
Abstract:
ObjectiveTo investigate the influence of Pharmacy Intravenous Admixture Services (PIVAS) on the establishment, subordination and work content of the professional group of centralized intravenous drug allocation management in the local area.MethodsA questionnaire survey was conducted among the persons in charge of PIVAS in medical institutions by the Working Committee of Centralized Intravenous Drug Allocation of Chinese Pharmacists Association. ResultsAmong 761 PIVAS, 665 (87.39%) from 30 provinces(autonomous region, municipalities directly under the central government) had established professional groups. 96 (12.61%)PIVAS from 22 provinces(autonomous region, municipalities directly under the central government) did not establish professional groups. Among the 665 PIVAS that established professional groups, 365 (54.89%) of the professional groups in the provinces(autonomous region, municipalities directly under the central government) where PIVAS were located belonged to the provincial and municipal health administrative departments and the centers of pharmacy, pharmaceutical management, clinical pharmacy, intravenous drug allocation, and medical quality control under their leadership. Conclusion The construction of provincial professional group for centralized intravenous drug allocation management in China was relatively weak, and it failed to play a core role in supervision and guidance. The functional positioning of provincial professional group for centralized intravenous drug allocation management should be strengthened to improve the quality and efficiency of supervision and management.

参考文献/References:

［1］卫生部办公厅.关于印发《静脉用药集中调配质量管理规范》的通知：卫办医政发〔2010〕62号［EB/OL］.(2010-04-23)［2023-11-26］.https://www.gov.cn/gongbao/content/2020/content_5522549.htm.［2］黄石市卫生健康委.《湖北省医疗机构静脉用药集中调配质量管理办法》政策解读［EB/OL］.(2022-12-02)［2023-11-26］.http://wjw.huangshi.gov.cn/xxgk_21/zc/zcjd/202301/t20230119_984348.html.［3］海南省卫生健康委.海南省卫生健康委员会转发国家卫生健康委办公厅关于印发静脉用药调配中心建设与管理指南（试行）的通知［EB/OL］.(2021-12-29)［2023-11-26］.https://wst.hainan.gov.cn//swjw/xxgk/0200/0202/202112/t20211230_31221 65.html.［4］石屏县人民医院.州检查组对石屏县人民医院静脉用药调配中心等药学工作进行现场督导检查［EB/OL］.(2023-07-26)［2023-11-26］.https://mp.weixin.qq.com/ s?__biz=MzA5OTUwODU4OQ==&mid=2650387509&idx=1&sn=3493b30f799d2a5c3aaf0158b9b81038&chksm=888c5c37bffbd521a712c25234c35de41660f 52dd07392c36b9155256cafc5dac168ab3e4cb d&scene=27.［5］国家卫生健康委.静脉用药调配中心建设与管理指南（试行）［EB/OL］.（2021-12-10）［2022-01-20］.http://www.gov.cn/zhengce/zhengceku/2021-12/21/ content_5663666.htm.［6］吴永佩，颜 青.静脉用药调配中心建设与管理指南（试行）答疑［M］.北京：科学技术文献出版社，2023：32-33.［7］张峻,吴 迪,吴永佩.加强监督与技术指导，促进PIVAS规范化建设：《静脉用药调配中心建设与管理指南》系列解读(一)［J］.中国医院药学杂志，2022，42(19)：1970-1972.［8］卢 智. 医院静脉用药集中调配模式的建设与管理实践研究［D］.广州：南方医科大学,2014.［9］常乐蒙,解春花,孟庆楠，等.静脉用药调配中心在临床合理用药的应用研究［J］.中国医药科学,2022,12(10):104-106，192.［10］乔乐天. 建立静脉药物调配中心提升临床医疗服务质量［D］.郑州：郑州大学,2018.［11］国家卫生健康委.2022年我国卫生健康事业发展统计公报［EB/OL］.（2023-10-12）［2023-12-10］.http://www.nhc.gov.cn/guihuaxxs/s3585u/202309/6707c48f 2a2b420fbfb739c393fcca92.shtml.［12］李国春，张文军，邓谷霖，等.医疗机构应重视静脉用药调配中心项目建设的规划与实施：《静脉用药调配中心建设与管理指南》系列解读（十三）［J］.中国医院药学杂志,2023,43(9):950-952.［13］左 玮，周 亮，高黛慧，等.我国二级及以上综合医院2020年住院患者静脉输液使用情况调研［J］.中国卫生质量管理，2023,30(4)：30-33.

相似文献/References:

[1]李柯 姜德春 张培 李南 赵颖波 顾红燕.基于FMEA的PIVAS成品输液交接流程优化研究[J].中国卫生质量管理,2024,31(04):016.[doi:10.13912/j.cnki.chqm.2024.31.4.04]
　LI Ke,ZHANG Pei,LI Nan,et al.Optimization of Finished Products Infusion Handover Process in PIVAS Based on FMEA[J].Chinese Health Quality Management,2024,31(04):016.[doi:10.13912/j.cnki.chqm.2024.31.4.04]

更新日期/Last Update: 2024-04-15